Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 81
Filter
Add more filters










Publication year range
1.
Environ Toxicol Pharmacol ; 53: 151-157, 2017 Jul.
Article in English | MEDLINE | ID: mdl-28586725

ABSTRACT

The aim of this study was to determine Cd (cadmium) and As (arsenic) contents in human breast cancer tissues, investigate their interactions with Se (selenium) and Fe (iron), and assess their further implications for tumor progression. Metal contents were determined in 42 tissue sets (tumor and adjacent tissue) collected from 42 women diagnosed with primary breast cancer. Analytical methods included AAS and ICP-MS techniques. Significantly higher contents of Cd (p=0.0003), Se (p<0.0001) and Fe (p=0.0441) whereas significantly lower content of As (p<0.0001) were observed in tumors as compared to adjacent tissues. There was a significant positive correlation between Cd and As contents in tumor tissue. However, only Cd was significantly associated with histological type of tumor, its size, grading and progesterone receptor status. This study support the role of Cd in breast cancer risk and progression. The possible link between As exposure and breast cancer is still not clear.


Subject(s)
Arsenic/analysis , Breast Neoplasms/chemistry , Cadmium/analysis , Iron/analysis , Selenium/analysis , Adult , Aged , Aged, 80 and over , Breast/chemistry , Breast Neoplasms/pathology , Female , Humans , Middle Aged , Smoking
2.
Eur J Nutr ; 55(8): 2469-2484, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26658762

ABSTRACT

PURPOSE: Selenium, both essential and toxic element, is considered to protect against cancer, though human supplementation trials have generated many inconsistent data. Genetic background may partially explain a great variability of the studies related to selenium and human health. The aim of this study was to assess whether functional polymorphisms within two selenoprotein-encoding genes modify the response to selenium at the level of oxidative stress, DNA damage, and mRNA expression, especially in the individuals with a relatively low selenium status. METHODS: The trial involved 95 non-smoking individuals, stratified according to GPX1 rs1050450 and SEPP1 rs3877899 genotypes, and supplemented with selenium yeast (200 µg) for 6 weeks. Blood was collected at four time points, including 4 weeks of washout. RESULTS: After genotype stratification, the effect of GPX1 rs1050450 on lower GPx1 activity responsiveness was confirmed; however, in terms of DNA damage, we failed to indicate that individuals homozygous for variant allele may especially benefit from the increased selenium intake. Surprisingly, considering gene and time interaction, GPX1 polymorphism was observed to modify the level of DNA strand breaks during washout, showing a significant increase in GPX1 wild-type homozygotes. Regardless of the genotype, selenium supplementation was associated with a selectively suppressed selenoprotein mRNA expression and inconsistent changes in oxidative stress response, indicating for overlapped, antioxidant, and prooxidant effects. Intriguingly, DNA damage was not influenced by supplementation, but it was significantly increased during washout. CONCLUSIONS: These results point to an unclear relationship between selenium, genotype, and DNA damage.


Subject(s)
DNA Damage/drug effects , Dietary Supplements , Glutathione Peroxidase/genetics , Oxidative Stress/drug effects , Selenium/toxicity , Selenoproteins/genetics , Adolescent , Adult , Alleles , Body Mass Index , Female , Genotype , Genotyping Techniques , Glutathione Peroxidase/blood , Humans , Lipid Peroxidation/drug effects , Male , Middle Aged , Polymorphism, Single Nucleotide , RNA, Messenger/genetics , RNA, Messenger/metabolism , Saccharomyces cerevisiae , Selenium/administration & dosage , Selenium/blood , Selenoproteins/blood , Young Adult , Glutathione Peroxidase GPX1
3.
Clin Biochem ; 48(18): 1235-40, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26197083

ABSTRACT

OBJECTIVES: To investigate the clinical correlates and prognostic utility of MMP, VEGF and TIMP genes expression in bladder cancer (BCa) recurrence. METHODS: Expression of MMP1, MMP2, MMP9, VEGFA and TIMP1, TIMP3 was analyzed by qRT-PCR using SYBR Green in peripheral blood leukocytes (PBLs) of BCa patients at two time points (diagnosis (n=40), and first recurrence (n=40)) and an age-matched group of healthy controls (n=100). Plasma concentrations of MMP1 (pro- and active forms) were measured using ELISA in BCa patients. RESULTS: The expression of MMP1 mRNA was significantly lower in BCa patients with first recurrence compared to control (p=0.019). Expression of other genes did not differ significantly between the groups. MMP9 gene expression was associated with differentiation grade (p=0.043), with the highest expression in poorly differentiated tumors (G3) and was higher in smokers than in non-smokers (p=0.039) in BCa patients at diagnosis. The results at two time points showed that MMP9 and VEGFA genes expression was increased in patients with moderately differentiated BCa (p=0.029), and advanced pathologic stage (p=0.048), respectively. Moreover, gene expression of TIMP1 was increased for G3 (p=0.043), and was decreased for early recurrence (p=0.003). CONCLUSIONS: Our study suggests that the expression of MMP9 in PBLs of BCa patients at diagnosis is associated with the differentiation grade of the BCa, and smoking status. Genes expression of MMP9, VEGFA and TIMP1 in PBLs may play a pivotal role in regulation of progression of BCa. Additionally, TIMP1 gene expression may be important factor for early recurrence of BCa.


Subject(s)
Biomarkers, Tumor/blood , Matrix Metalloproteinase 9/genetics , Neoplasm Recurrence, Local/diagnosis , Tissue Inhibitor of Metalloproteinase-1/genetics , Urinary Bladder Neoplasms/diagnosis , Vascular Endothelial Growth Factor A/genetics , Biomarkers, Tumor/genetics , Case-Control Studies , Disease Progression , Female , Gene Expression , Humans , Leukocytes, Mononuclear/metabolism , Leukocytes, Mononuclear/pathology , Male , Matrix Metalloproteinase 1/blood , Matrix Metalloproteinase 1/genetics , Matrix Metalloproteinase 2/blood , Matrix Metalloproteinase 2/genetics , Matrix Metalloproteinase 9/blood , Neoplasm Grading , Neoplasm Recurrence, Local/blood , Neoplasm Recurrence, Local/genetics , Neoplasm Recurrence, Local/pathology , Neoplasm Staging , Prognosis , Risk Factors , Smoking/physiopathology , Tissue Inhibitor of Metalloproteinase-1/blood , Tissue Inhibitor of Metalloproteinase-3/blood , Tissue Inhibitor of Metalloproteinase-3/genetics , Urinary Bladder Neoplasms/blood , Urinary Bladder Neoplasms/genetics , Urinary Bladder Neoplasms/pathology , Vascular Endothelial Growth Factor A/blood
4.
Neoplasma ; 60(2): 123-8, 2013.
Article in English | MEDLINE | ID: mdl-23259779

ABSTRACT

Nuclear factor (erythroid-derived 2)-like 2 (NRF2) is an oxidant-responsive transcription factor involved in induction of antioxidant genes. We assessed NRF2 and selected NRF2-modulated gene expression: glutathione S-transferase A1 and P1 (GSTA1 and GSTP1), mitochondrial superoxide dismutase (SOD2) in blood leukocytes of 51 bladder cancer patients and 90 control males. A significant up-regulation of SOD2 expression (P=0.002) was observed in leukocytes of patients. NRF2 expression was positively correlated with GSTP1 and with SOD2 mRNA level, both in patients and controls. These data suggest disturbances in SOD2 transcription in circulating blood leukocytes of males with bladder cancer. Moreover, concomitant constitutive expression of NRF2 and its target genes may suggest important role of NRF2 transcription factor in positive regulation of antioxidant genes, resulted in enhanced cytoprotection in human peripheral blood leukocytes.


Subject(s)
Leukocytes/metabolism , NF-E2-Related Factor 2/genetics , Urinary Bladder Neoplasms/genetics , Aged , Gene Expression Regulation, Neoplastic , Glutathione S-Transferase pi/genetics , Glutathione Transferase/genetics , Humans , Male , Middle Aged , NF-E2-Related Factor 2/physiology , RNA, Messenger/analysis , Superoxide Dismutase/genetics , Urinary Bladder Neoplasms/metabolism
5.
Neoplasma ; 59(3): 237-47, 2012.
Article in English | MEDLINE | ID: mdl-22296495

ABSTRACT

The family of human matrix metalloproteinases (MMPs) consists of 24 zinc- and calcium-dependent proteolytic enzymes. MMPs are divided into six subgroups, in terms of differences in the substrate specificity with structural domain architecture. These enzymes are involved in many physiological processes, such as skeletal development, wound healing, scar formation, as well as carcinogenesis. MMPs, fulfilling its function of degradation of extracellular matrix components, are involved in one of the stages of angiogenesis enabling the development, growth and spread of the primary tumor. Therefore, the search for the common polymorphic variants of MMPs, new genetic markers as prognostic factors in breast cancer progress seems to be understandable.The minireview presents the results of 19 case-control or prospective studies concerning the association of SNPs of genes encoding nine MMPs: MMP-1, -2, -3, -7, -8, -9, -12, -13, -21 with the breast cancer risk, progression and survival.


Subject(s)
Breast Neoplasms/enzymology , Breast Neoplasms/genetics , Matrix Metalloproteinases/genetics , Polymorphism, Genetic/genetics , Female , Humans , Prognosis
6.
J Biol Chem ; 275(17): 12879-88, 2000 Apr 28.
Article in English | MEDLINE | ID: mdl-10777586

ABSTRACT

Vimentin is a component of the eukaryotic cytoskeleton belonging to the family of intermediate filament proteins. It exhibits a complex pattern of tissue- and development-specific expression. It is also a marker of the metastatic potential of many tumor cells. Previously, the human vimentin promoter was shown to contain several regions for the binding of positive and negative acting regulatory factors. Until now, the silencer element, which shuts down vimentin synthesis in selected tissues during development, was not precisely localized; nor was its binding protein known. In vivo DMS footprinting by ligation-mediated PCR delineated the position of guanine residues important to vimentin expression. Transient transfection assays in HeLa cells of various vimentin 5'-end promoter sequences and mutants thereof precisely defined two regulatory elements, a negative element and an adjoining positive acting element. Band shift assays, UV cross-linking, and Southwestern blot analysis confirm that the silencer element specifically binds a protein. Several lines of evidence show that ZBP-89, a zinc finger, Kruppel-like repressor protein is vimentin's silencer element binding factor. Co-immunoprecipitation and DNA affinity chromatography prove that Sp1 heterodimerizes with ZBP-89 when bound to the silencer element to yield a DNA-protein complex whose mobility is indistinguishable from that displayed by HeLa nuclear extract in band shift assays.


Subject(s)
DNA-Binding Proteins/metabolism , Regulatory Sequences, Nucleic Acid , Sp1 Transcription Factor/metabolism , Transcription Factors/metabolism , Vimentin/genetics , Base Sequence , Cell Nucleus/metabolism , Chloramphenicol O-Acetyltransferase/metabolism , Chromatography, Affinity , DNA Footprinting , DNA-Binding Proteins/genetics , Gene Expression Regulation , Guanine/chemistry , HeLa Cells , Humans , Molecular Sequence Data , Mutagenesis, Site-Directed , Plasmids , Polymerase Chain Reaction , Promoter Regions, Genetic , Protein Binding , Recombinant Proteins/metabolism , Transcription Factors/genetics , Transfection , Tumor Cells, Cultured
7.
Gene ; 235(1-2): 69-75, 1999 Jul 22.
Article in English | MEDLINE | ID: mdl-10415334

ABSTRACT

Vimentin is an intermediate filament protein normally expressed in cells of mesenchymal origin. The promoter of the human vimentin gene (-1416 to +73) was shown to contain two positive-acting regions, separated by a negative region, and at least eight GC-boxes as determined by sequence homology (Rittling, S.R., Baserga, R., 1987. Mol. Cell. Biol. 7, 3908-3915). We have analyzed the region -900 to +41 for protein binding by in vivo footprinting experiments using ligation-mediated PCR. For the various GC-boxes, we detect protein binding only to that GC-box (at position -64 and -55) closest to the transcriptional start site. Transient transfection assays of various vimentin 5'-end fragments and mutations thereof fused to the reporter gene cat indicate that this sequence is indispensable for promoter function regardless of the inclusion of upstream DNA sequences. In vitro binding studies confirm that this region binds protein specifically. We suggest that this GC-box and its binding factor are required for regulated expression of the human vimentin gene.


Subject(s)
Gene Expression Regulation , Response Elements/genetics , Vimentin/genetics , Binding, Competitive , Cell Extracts , DNA/genetics , DNA/metabolism , DNA Footprinting , DNA Methylation , DNA-Binding Proteins/metabolism , Genes, Reporter/genetics , HeLa Cells , Humans , Mutation , Polymerase Chain Reaction , Promoter Regions, Genetic/genetics , Sp1 Transcription Factor/physiology , Transfection , Tumor Cells, Cultured
8.
Exp Clin Endocrinol Diabetes ; 107(1): 85-8, 1999.
Article in English | MEDLINE | ID: mdl-10077362

ABSTRACT

The aim of the study was to examine the effects of reserpine on the plasma levels of adrenaline, noradrenaline, cortisol and alpha-neoendorphin in sheep under control conditions and during walking exercise. One hour of walking (5 km/h) caused a significant increase in both catecholamines and cortisol between 10 and 30 min of stress, and transiently decreased the level of alpha-neoendorphin at the same time. Reserpine at the dose of 0.3 mg/kg i.v. given before stress significantly lowered the basal levels of all tested parameters. A combination of the reserpine and walking exercise significantly attenuated the stress-induced changes in the plasma level of measured hormones.


Subject(s)
Catecholamines/blood , Endorphins/blood , Hydrocortisone/blood , Physical Exertion/physiology , Protein Precursors/blood , Reserpine/pharmacology , Sheep/physiology , Adrenergic Uptake Inhibitors/pharmacology , Animals , Female , Stress, Physiological/blood , Walking
9.
Carbohydr Res ; 307(3-4): 263-70, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9675367

ABSTRACT

By Lewis acid catalysed allylic rearrangement reactions of various glycals with glycerol derivatives 2,3-unsaturated mono- and disaccharide glycosyl glycerol derivatives were obtained in good yields. A triglycosyl glycerol was successfully synthesized in a straightforward three step way from 3,4,6-tri-O-acetyl-1,5-anhydro-2-deoxy-D-arabino-hex-1-enitol.


Subject(s)
Deoxy Sugars/chemistry , Glycerol/analogs & derivatives , Glycerol/chemical synthesis , Oligosaccharides/chemical synthesis , Glycerol/chemistry , Magnetic Resonance Spectroscopy
10.
Nature ; 393(6681): 187-91, 1998 May 14.
Article in English | MEDLINE | ID: mdl-9603525

ABSTRACT

Initiation of transcription of a gene from a core promoter region by RNA polymerase II requires the assembly of several initiation factors to form a preinitiation complex. Assembly of this complex is thought to be nucleated exclusively by the sequence-specific binding of the TFIID transcription factor complex, which is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAF(II)s), to the different promoters. Here we isolate and characterize a new multiprotein complex that does not contain either TBP or a TBP-like factor but is composed of several TAF(II)s and other proteins. This complex can replace TFIID on both TATA-containing and TATA-lacking promoters in in vitro transcription assays. Moreover, an anti-TBP antibody that inhibits TBP- and TFIID-dependent transcription does not inhibit activity of this new complex. These results indicate that TBP-free RNA polymerase II mediated transcription may be able to occur in mammalian cells and that multiple preinitiation complexes may play an important role in regulating gene expression.


Subject(s)
DNA-Binding Proteins/physiology , RNA Polymerase II/metabolism , TATA-Binding Protein Associated Factors , Transcription Factors, TFII/physiology , Transcription Factors/physiology , Transcription, Genetic , DNA Footprinting , HeLa Cells , Humans , TATA-Box Binding Protein , Transcription Factor TFIID , Transcriptional Activation
12.
Zentralbl Veterinarmed A ; 43(9): 521-30, 1996 Nov.
Article in English | MEDLINE | ID: mdl-8968161

ABSTRACT

Heat stress is accompanied by a decrease in basal metabolic rate and plasma thyroid hormones. Unlike 3,5,3'-triiodothyronine (T3) and thyroxine (T4), 3,3',5'-triiodothyronine (rT3) displays hypometabolic properties and antagonizes the hypermetabolic effect of T3. This study analyses the role of rT3 in heat (38-39 degrees C) stressed immature chickens. Two experiments which differed in frequency of rT3 injections (one or two times a day), duration of heat stress (72 or 48 h) and blood sampling were performed. The dose was 14 micrograms rT3/100 gb.wt./injection (s.c.). It has been shown that rT3 treatment aggravates heat stress symptoms (enhances circulating corticosterone, catecholamines and free fatty acids) and increases mortality. The critical survival time of the rT3 treated and heated birds was at first 24 h of stress. No more chickens died during the next days of the experiment despite the continuation of rT3 injection, suggesting that rT3 might disturb the adaptation to heat. Reverse T3 in heat stressed chickens led to the highest reduction in food consumption (69.9%) and body weight gain (14.0% compared to initial weight). The opposite effect in water consumption (216.9%) was observed. In a neutral environment, rT3 significantly suppressed body temperature 6 h after injection (40.4; control; 41.1 degrees C), confirming its hypometabolic properties. However, at the same time rT3 significantly enhanced body temperature in heat stress (43.03 versus heated control 42.56 degrees C). In addition, in rT3 treated birds decreased plasma triglycerides (TG; 24.3%) and increased plasma free fatty acids (FFA; neutral temperature; 26.4% heat stress: 57%) were demonstrated. A correlation between corticosterone and FFA (r = 0.52) shows that some of the FFA may originate from lipolysis since hormones of the pituitary-adrenocortical axis accelerate lipolysis. The remaining part of the increased FFA appears to be due to suppressed utilization of FFA as a consequence of hypometabolic properties of rT3. Low and negative relation between TG and FFA (r = -0.26; P < 0.05) may support such an assumption. The two times higher peak of corticosterone in the rT3 and the overheated group, as compared to the heated control, occurred at 6 h of heat stress and indicates that rT3 increases the unfavourable effect of high temperature. This was also confirmed by elevated plasma adrenaline and noradrenaline in rT3-injected and heated chickens (55.5 and 120%, respectively). However, a single and two times higher peak of adrenaline at 24 h of heat stress was observed in saline treated birds, but not in rT3 supplemented animals, suggesting that this difference might explain one of the factors responsible for high mortality. In conclusion, the results obtained demonstrate that physiological doses of rT3, a hypometabolic hormone, enhance the unfavourable effect of heat stress in chickens.


Subject(s)
Chickens/physiology , Heat Stress Disorders/veterinary , Poultry Diseases/physiopathology , Triiodothyronine/pharmacology , Animals , Body Mass Index , Body Temperature/physiology , Chickens/blood , Corticosterone/blood , Dose-Response Relationship, Drug , Eating/physiology , Epinephrine/blood , Fatty Acids, Nonesterified/blood , Heat Stress Disorders/blood , Heat Stress Disorders/physiopathology , Norepinephrine/blood , Oxygen Consumption/physiology , Poultry Diseases/blood , Thyroxine/blood , Triglycerides/blood , Triiodothyronine/blood
13.
Acta Paediatr ; 85(6): 688-91, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8816205

ABSTRACT

We evaluated the potential of the carboxy-terminal propeptide of type I procollagen (PICP), the carboxy-terminal telopeptide of collagen I (ICTP), and the amino-terminal propeptide of type III procollagen (PIIINP) to differentiate osteogenesis imperfecta (OI) from Ehlers-Danlos syndrome (EDS) and idiopathic juvenile osteoporosis (IJO) in paediatric patients. Markedly decreased serum concentrations of PICP were found in type I OI, while in IJO they were much less diminished, and in EDS they were near to normal. In type III and IV OI, the serum PICP level was lowered in prepubertal patients, whereas at puberty it was comparable to that in controls. Serum ICTP and PIIINP levels in patients with OI did not differ significantly from the levels in EDS and IJO. Measurements of serum PICP levels seem to be useful in discriminating OI from EDS and IJO in prepubertal children. In pubertal children, however, they lose their diagnostic power.


Subject(s)
Collagen/blood , Ehlers-Danlos Syndrome/metabolism , Osteogenesis Imperfecta/metabolism , Osteoporosis/metabolism , Peptide Fragments/blood , Peptides/blood , Procollagen/blood , Adolescent , Age Factors , Biomarkers/blood , Case-Control Studies , Child , Child, Preschool , Collagen Type I , Diagnosis, Differential , Discriminant Analysis , Humans , Puberty
14.
Acta Biochim Pol ; 43(4): 603-10, 1996.
Article in English | MEDLINE | ID: mdl-9104496

ABSTRACT

Previously described methods of purification of hemolymph juvenile hormone-binding protein (hJHBP) from Lepidoptera were tedious and required multiple steps. These methods resulted in low protein yield (Kramer et al., 1976; Goodman et al., 1978; Peterson et al., 1982; Park et al., 1993; Ozyhar & Kochman, 1987). In this report a simple method of purification of hJHBP from Galleria mellonella (L.) larvae is described. Monoclonal antibodies against hJHBP were obtained and crosslinked to CNBr-activated Sepharose 4B. The hemolymph of G. mellonella was centrifuged and then chromatographed on Sephadex G-200 gel filtration column. Juvenile-hormone-binding activity containing material from Sephadex G-200 column was subjected to purification on an immunoaffinity column. Bound protein was eluted from anti-hJHBP Sepharose 4B gel by lowering pH to 3.0 with 200 mM citric acid 200 mM Na2HPO4 buffer. This method resulted in 320-fold purification of G. mellonella hJHBP with 56% yield.


Subject(s)
Carrier Proteins/isolation & purification , Chromatography, Affinity/methods , Hemolymph/metabolism , Insect Proteins , Juvenile Hormones/blood , Animals , Carrier Proteins/blood , Chromatography, Gel , Chromatography, Ion Exchange , Electrophoresis, Polyacrylamide Gel , Lepidoptera
16.
Phys Rev D Part Fields ; 52(4): 2341-2354, 1995 Aug 15.
Article in English | MEDLINE | ID: mdl-10019451
17.
Klin Oczna ; 96(12): 385-6, 1994 Dec.
Article in Polish | MEDLINE | ID: mdl-7715162

ABSTRACT

Ryster Optik occlusive folia were applied in 75 children with lowgrade amblyopia. Improvement of the visual acuity and binocular vision were achieved in all cases.


Subject(s)
Amblyopia/therapy , Sensory Deprivation , Child , Child, Preschool , Humans , Treatment Outcome , Visual Acuity
18.
Agents Actions ; 41 Spec No: C73-4, 1994 Jun.
Article in English | MEDLINE | ID: mdl-7976810

ABSTRACT

The social stress of crowding for 3, 7 and 14 days considerably reduced the increase in serum corticosterone elicited by intracerebroventricular administration of isoprenaline, a beta-adrenergic agonist, on the 3rd and 7th days of crowding. The corticosterone response to clonidine, an alpha 2-adrenergic agonist, was significantly diminished only after 3 days of crowding and this reduction was paralleled by a significant decrease in hypothalamic histamine content. The stimulatory effect of phenylephrine, an alpha 1-adrenergic agonist, was not significantly changed by crowding stress. Social crowding stress caused almost total and persistent reduction in the hypothalamic-pituitary-adrenocortical (HPA) responsiveness to noradrenaline which stimulates the HPA axis via both alpha- and beta-adrenergic receptors.


Subject(s)
Corticosterone/blood , Crowding/physiopathology , Hypothalamo-Hypophyseal System/physiology , Receptors, Adrenergic/physiology , Stress, Psychological/blood , Animals , Clonidine/pharmacology , Hypothalamo-Hypophyseal System/drug effects , Injections, Intraventricular , Isoproterenol/pharmacology , Male , Norepinephrine/pharmacology , Phenylephrine/pharmacology , Rats , Rats, Wistar
19.
Pacing Clin Electrophysiol ; 17(4 Pt 1): 627-36, 1994 Apr.
Article in English | MEDLINE | ID: mdl-7516546

ABSTRACT

Eleven resting patients with an implanted DDD pacemaker were studied. After 30 minutes of AV sequential pacing at a rate of 80 beats/min with three consecutive atrioventricular delays (AVDs; 100, 150, and 200 msec) peripheral venous blood was drawn for further analyses by specific radioimmunoassays of atrial natriuretic peptide (ANP) and the ANP second messenger, cyclic guanosine monophosphate (cGMP). Relative changes in left ventricular (LV) stroke volume following alterations of AVD were assessed by means of pulsed-Doppler echocardiography through measurement of LV outflow time-velocity integrals (TVI). The optimal AVD (oAVD) was defined in individual patients as that which was associated with the greatest TVI and with improvement over both other AVDs of more than 4%. The oAVD was found in nine patients. For these nine patients no significant differences in either plasma ANP or cGMP between various AVDs were observed. However, we found such differences with respect to values measured at oAVD; both ANP and cGMP levels were lowest at oAVD. Pooling together the data obtained in 11 patients at three AVDs, a positive correlation between ANP and cGMP levels was found (r = 0.7, P < 0.0001, n = 33). Moreover, changes of plasma ANP and cGMP induced by every AVD increment of 50 msec were also correlated (r = 0.6, P < 0.01, n = 22). It is concluded that in AV sequential pacing at rest plasma ANP reaches minimal levels at the AVD, which provides the best LV performance. Although levels of cGMP changed in parallel with those of ANP, low relative values of cGMP differences may limit the usefulness of cGMP assays in optimization of the AVD.


Subject(s)
Atrial Natriuretic Factor/blood , Atrioventricular Node/physiology , Cardiac Pacing, Artificial/methods , Cyclic GMP/blood , Ventricular Function, Left/physiology , Adult , Aged , Cardiac Output/physiology , Echocardiography, Doppler , Electrocardiography , Female , Humans , Male , Middle Aged , Mitral Valve/physiopathology , Pacemaker, Artificial , Stroke Volume/physiology , Time Factors , Ventricular Pressure/physiology
20.
Pol Tyg Lek ; 48 Suppl 3: 20-3, 1993 Nov.
Article in Polish | MEDLINE | ID: mdl-8309831

ABSTRACT

Clinical course of the idiopathic juvenile osteoporosis (IJO) was monitored in the group of 45 patients of both sexes with diagnosed disease, verified during follow-up period. The aim of the study was to evaluate the relationship between clinical symptoms and the results of biochemical, anthropometric, and densitometric measurements. An analysis of the obtained data enabled to distinguish the acute and chronic IJO phases. Evolution of the acute phase into chronic one was manifested by the cessation of pain and pathological gait stereotype, normalization of muscular strength, anthropometric parameters and urinary Pyr and DPyr excretion, as well as improvement in bone density. Hypercalciuria and increased urinary excretion of Pyr and DPyr, observed in the acute phase of IJO, may indicate that bone resorption exceeded bone formation. Tendency to maintain of alkaline phosphatase activity within lower limits of the normal values with slight increase during an improvement of densitometric parameters suggested transient osteoblast dysfunction.


Subject(s)
Bone Density/physiology , Osteoporosis/physiopathology , Adolescent , Alkaline Phosphatase/metabolism , Child , Child, Preschool , Female , Humans , Male , Monitoring, Physiologic , Retrospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL